141 related articles for article (PubMed ID: 9790043)
1. Scintigraphic evaluation of malignant melanoma lesions with Tc-99m tetrofosmin.
Alonso O; Martinez M; Mut F; Bruno J; Delgado L; Lago G; Nuñez M; Bazzano C; Espasandin J; Touya E
Clin Nucl Med; 1998 Oct; 23(10):683-5. PubMed ID: 9790043
[TBL] [Abstract][Full Text] [Related]
2. Scintigraphic detection of invasive cutaneous malignant melanoma with Tc-99m MIBI.
Alonso O; Martinez M; Lago G; Bazzano C; Saadoun A; Mut F; Delgado L; Espasandin J; Touya E
Clin Nucl Med; 1996 Jul; 21(7):557-9. PubMed ID: 8818470
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
4. [Detection of melanoma metastases with Tc-99m-tetrofosmin].
Rettenbacher L; Koller J; Kässmann H; Galvan G
Nuklearmedizin; 2000; 39(4):97-101. PubMed ID: 10919159
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m MIBI scintigraphy in a patient with primary and metastatic malignant melanoma.
Jang Kim S; Won Seok J; Ju Kim I; Ki Kim Y
Clin Nucl Med; 2002 May; 27(5):351-3. PubMed ID: 11953570
[TBL] [Abstract][Full Text] [Related]
6. Detection and follow-up of metastatic melanoma before and after high-dose regional chemotherapy by isolated limb perfusion with Tc-99m tetrofosmin.
Rettenbacher L; Koller J; Kässmann H; Galvan G
Clin Nucl Med; 1999 Dec; 24(12):976-7. PubMed ID: 10595481
[No Abstract] [Full Text] [Related]
7. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-tetrofosmin: a new agent for melanoma imaging?
Meghdadi S; Karanikas G; Schlagbauer-Wadl H; Jansen B; Chehne F; Rodrigues M; Pehamberger H; Sinzinger H
Anticancer Res; 1998; 18(4A):2759-62. PubMed ID: 9703942
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma.
Kim SJ; Kim IJ; Kim YK
Clin Nucl Med; 2002 Jan; 27(1):30-3. PubMed ID: 11805481
[TBL] [Abstract][Full Text] [Related]
10. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
Adalet I; Demirkale P; Unal S; Oůz H; Alagöl F; Cantez S
Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
12. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
14. Preoperative evaluation of sentinel lymph node status in melanoma by means of (99m)Tc-MIBI and lymphoscintigraphy: a case report.
Alonso O; Martínez M; Lago G; Espasandin J
J Nucl Med Technol; 2001 Sep; 29(3):152-3. PubMed ID: 11564839
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
16. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Breslow thickness and Technetium-99m-sestamibi uptake in cutaneous melanoma.
Masiero N; Costa MM; Masiero PR; Rosa L; Bakos R; Cartell A; Migliavacca A; Bakos L
Eur J Dermatol; 2013; 23(4):467-70. PubMed ID: 23816542
[TBL] [Abstract][Full Text] [Related]
18.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI imaging of cutaneous AIDS-associated Kaposi's sarcoma.
Peer FI; Pui MH; Mosam A; Rae WI
Int J Dermatol; 2007 Feb; 46(2):166-71. PubMed ID: 17269969
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
